![Jonathan Laifer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Laifer
Private Equity Investor chez
Cobepa North America, Inc.
Profil
Jonathan Laifer formerly worked at Gemini Bioproducts LLC, as Director, Arsenal Capital Management LP, as Principal from 2021 to 2025, The Goldman Sachs Group, Inc., as Investment Banking Associate, and BelHealth Investment Partners LLC, as Senior Associate.
Mr. Laifer received his undergraduate degree in 2011 from Emory University and Masters Business Admin degree in 2016 from The Wharton School of the University of Pennsylvania.
Postes actifs de Jonathan Laifer
| Sociétés | Poste | Début |
|---|---|---|
Cobepa North America, Inc.
 Cobepa North America, Inc. Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01/01/2025 |
Anciens postes connus de Jonathan Laifer
| Sociétés | Poste | Fin |
|---|---|---|
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Private Equity Investor | 01/06/2025 |
BelHealth Investment Partners LLC
 BelHealth Investment Partners LLC Investment ManagersFinance BelHealth Investment invests in lower middle market healthcare companies located in the United States. The firm focuses on companies with an enterprise value of USD 20 to 100 million, revenue of USD 10 to 100 million and EBITDA of USD 2 to 10 million. It acquires majority position and provides financing for buyout transactions with an investment size of USD 20 to 50 million. | Analyste en capital-investissement | 31/12/2020 |
Gemini Bioproducts LLC
 Gemini Bioproducts LLC BiotechnologyHealth Technology Manufactures cell culture media, sera, and other reagents to the scientific community | Directeur/Membre du Conseil | - |
| THE GOLDMAN SACHS GROUP, INC. | Analyste en capital-investissement | - |
Formation de Jonathan Laifer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
The Goldman Sachs Group, Inc.
 The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Finance |
BelHealth Investment Partners LLC
BelHealth Investment Partners LLC Investment ManagersFinance BelHealth Investment invests in lower middle market healthcare companies located in the United States. The firm focuses on companies with an enterprise value of USD 20 to 100 million, revenue of USD 10 to 100 million and EBITDA of USD 2 to 10 million. It acquires majority position and provides financing for buyout transactions with an investment size of USD 20 to 50 million. | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cobepa North America, Inc.
Cobepa North America, Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Gemini Bioproducts LLC
Gemini Bioproducts LLC BiotechnologyHealth Technology Manufactures cell culture media, sera, and other reagents to the scientific community | Health Technology |
Choisissez Zonebourse 
